• Wonder drug-capsule may one day replace

    From ScienceDaily@1:317/3 to All on Wednesday, April 19, 2023 22:31:44
    Wonder drug-capsule may one day replace insulin injection for diabetics


    Date:
    April 19, 2023
    Source:
    RMIT University
    Summary:
    Scientists have designed a new type of oral capsule that could mean
    pain- free delivery of insulin and other protein drugs. Protein
    drugs had proven challenging to deliver orally as the drugs degrade
    very quickly in the stomach -- until now.


    Facebook Twitter Pinterest LinkedIN Email
    FULL STORY ========================================================================== Scientists in Melbourne have designed a new type of oral capsule that
    could mean pain-free delivery of insulin and other protein drugs.


    ========================================================================== Co-lead researcher Professor Charlotte Conn, a biophysical chemist from
    RMIT University, said protein drugs had proven challenging to deliver
    orally as the drugs degrade very quickly in the stomach -- until now.

    "These types of drugs are typically administered with an injection --
    thousands of diabetics in Australia need insulin injections up to several
    times a day, which can be unpleasant for the patient and results in high healthcare costs," said Conn, from RMIT's School of Science.

    She said the new technology could also be used to deliver other protein
    drugs orally -- including a new type of oral antibiotic developed by
    the RMIT team that can avoid resistance by dangerous superbugs.

    "Other protein drugs such as monoclonal antibodies have been developed to
    treat inflammatory conditions, cancer and other diseases with a projected market value of about $400 billion by 2030," Conn said.

    An international patent application has been filed for RMIT's technology.

    Strong pre-clinical results provide optimism for a new way to deliver
    insulin The team has tested the new oral capsule with insulin in
    a pre-clinical study and the results have been published in the
    international journal Biomaterials Advances.

    "We think the results are really exciting, and we're doing a suite of pre- clinical testing so we can move to clinical trials as soon as possible,"
    Conn said.

    The research paper assessed the performance of the oral capsules with
    both fast-acting and slow-acting insulin.

    "When controlling the blood-sugar, you need a very fast response if
    you're eating a meal. That's known as fast-acting insulin," Conn said.

    A slow-acting form acts over a much longer timeframe -- up to a day
    or so -- to keep the insulin in the body steady. Most diabetics take a combination of both types of insulin.

    "We had excellent absorption results for the slow-acting form -- about
    50% better than injection delivery for the same quantity of insulin,"
    Conn said.

    The capsule achieved good absorption results for fast-acting insulin,
    but the significant lag in the insulin taking effect compared with
    injection delivery would likely make it less practical.

    "Our results show there is real promise for using these oral capsules
    for slow- acting insulin, which diabetics could one day take in addition
    to having fast- acting insulin injections," Conn said.

    "The oral capsules could potentially be designed to allow dosing
    over specific time periods, similar to injection delivery. We need
    to investigate this further, develop a way of doing so and undergo
    rigorous testing as part of future human trials." How does the team's
    drug capsule work? Dr Jamie Strachan, the first author on the paper,
    said the capsule protected the drug inside so that it passed safely
    through the stomach to the small intestine.

    "The capsule has a special coating designed to not breakdown in the low
    pH environment of the stomach, before the higher pH levels in the small intestine trigger the capsule to dissolve," said Strachan, from RMIT's
    School of Science.

    "We package the insulin inside a fatty nanomaterial within the capsule
    that helps camouflage the insulin so that it can cross the intestinal
    walls.

    "It's actually similar to how the Pfizer and the Moderna COVID vaccines
    work where the mRNA in those vaccines is also packaged within fats,
    helping to keep the drugs active and safe during delivery in the body."
    These vaccines contain mRNA, which is similar to DNA, to safely carry
    the instructions for making a viral protein within the body, activating
    our immune system.

    A cheaper and more efficient way to deliver protein drugs Dr Ce'line
    Vale'ry, a pharmaceutical scientist from RMIT and study co-author,
    said they used the same amount of insulin in the oral capsules and in
    the injection delivery.

    "For many pre-clinical trials the oral formulations by necessity contain
    much higher levels of insulin to achieve the same response as the
    injection delivery. This is not a very cost-effective way to deliver
    protein drugs which tend to be expensive," said Vale'ry, from RMIT's
    School of Health and Biomedical Sciences.

    "It's a great starting point but we need to do further trials to develop
    an alternative, pain-free method for the delivery of insulin and other
    protein drugs."
    * RELATED_TOPICS
    o Health_&_Medicine
    # Diabetes # Pharmacology # Hypertension # HIV_and_AIDS #
    Pregnancy_and_Childbirth # Pharmaceuticals # Dentistry
    # Medical_Devices
    * RELATED_TERMS
    o Analgesic o Antiretroviral_drug o Anti-obesity_drug
    o Antiviral_drug o Stimulant o Pharmaceutical_company o
    Biopharmaceutical o Psychedelic_properties

    ========================================================================== Story Source: Materials provided by RMIT_University. Original written
    by Will Wright. Note: Content may be edited for style and length.


    ========================================================================== Journal Reference:
    1. Jamie B. Strachan, Brendan Dyett, Stanley Chan, Brody McDonald, Ross
    Vlahos, Celine Valery, Charlotte E. Conn. A promising new oral
    delivery mode for insulin using lipid-filled enteric-coated
    capsules. Biomaterials Advances, 2023; 148: 213368 DOI:
    10.1016/j.bioadv.2023.213368 ==========================================================================

    Link to news story: https://www.sciencedaily.com/releases/2023/04/230419125104.htm

    --- up 1 year, 7 weeks, 2 days, 10 hours, 52 minutes
    * Origin: -=> Castle Rock BBS <=- Now Husky HPT Powered! (1:317/3)